TriipMiles

TriipMiles

ICO Ended
17,836 Views
Triip Pte. Ltd – a profitable travel startup founded in 2014, licensed by the Singapore Tourism Board, is doing a reverse ICO. We have been helping travellers book authentic local tours, hotel rooms and accommodations seamlessly in 227 countries with database capacity of 1.9M+ hotels and 6000+ local guides in the last four years. We are operating profitably and have had US$858,000 seed funding from 3 Venture Funds: Gobi Partners SEA, MAP2| Ventures and Gaiax Ventures.

Triip is known as a disruptor in the travel industry and has received recognition from various Tourism Boards in the form of awards and partnerships. Triip is an honour Board member of the Pacific Asia Travel Association (PATA) and active member of United Nation World Travel Organisation (UNWTO)’s Global Code of Ethics for Tourism.
9.6
TOTAL SCORE
9.2
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Bounty: Bounty
Pre-sale Time: 01 Feb 2019 - 21 Feb 2019
ICO Time: 23 Feb 2019 - 29 Mar 2019
Whitelist/KYC: Whitelist + KYC
Country: Singapore
Token info
Ticker: TIIM
Platform: Ethereum
Token Type: ERC20
Available for sale: 165,000,000 TIIM (33%)
Financial
Raised $ 700,000
Pre-sale Price : 1 TIIM = 0.015 USD
ICO Price: 1 TIIM = 0.0001136364 ETH
Accepting: ETH, TOMO, BTC, Fiat
Soft cap: 250,000 USD
Hard cap: 2,475,000 USD
Q2 2018
White paper release<br /> <br /> Complete ICO website for private & public sales<br /> <br /> Private sale<br /> <br /> Adding global partnerships
Q3 2018
Public sale<br /> <br /> Re-architect and streamline internal systems<br /> <br /> Launch Global Travel Entrepreneur Challenge 2018
Q4 2018
TriipMe supports payment and payout in TRIIPMILES<br /> <br /> Recruit city managers in 20 cities<br /> <br /> Launch Universal Travel Scoring system<br /> <br /> Integrating airport-pickups and car bookings in Asia
Q1 2019
Listing on additional exchanges<br /> <br /> Expansion of UTS to more partners<br /> <br /> Launch Global Sustainable Award for hotels and tours
Q2 2019
Launch decentralized approval and arbitration system<br /> <br /> Launch P2P referral system
Q3 2019
Launch Global Travel Entrepreneur Challenge 2019<br /> <br /> Leverage machine learning capabilities
2020
Launch Triip’s tour operator and hotel management software<br /> <br /> Launch Global Travel Entrepreneur Challenge 2020
Screenshots taken on 10 Jun 2018
Ho Viet Hai
CEO & Founder
Participates in a number of projects
Nguyen The Luan
CTO
Participates in a number of projects
Paul Wee
CFO
Participates in a number of projects
Yap Kwong Weng
Co-founder
Participates in a number of projects
Jun Ishikawa
East Asia Director
Participates in a number of projects
Jumpei Nishikawa
Japan Lead
Participates in a number of projects
Ha Lam
COO & Co-Founder
Participates in a number of projects
Stacey Lee
CSO
Participates in a number of projects
Son Doan
Blockchain Engineer
Participates in a number of projects
Vo Minh Tri
Growth Lead
Participates in a number of projects
Phan Tien Thanh
Operation
Participates in a number of projects
Calvin Kizana
Advisor
Participates in a number of projects
Hamza Khan
Advisor
Participates in a number of projects

Advisors (6)

Tiago C. Alves
VP Asia Pacific at AppCoins and Aptoide
Participates in a number of projects
Mario Hardy
CEO of the Pacific Asia Travel Association (PATA)
Participates in a number of projects
Long Vuong
CEO of TomoChain
Participates in a number of projects
Brian Leonard
CTO & Technical Cofounder at TaskRabbit
Participates in a number of projects
Victor Chua
Managing Director at Vynn Capital, Malaysia and Forbes Asia 30 Under 30.
Participates in a number of projects
Joel Ng
Chief Investment Officer, Partner at XSQ
Participates in a number of projects
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Pre-Sale
Antix
Antix creates hyper-realistic digital humans that bridge the gap between the real and virtual worlds. At the heart of Antix is an extensive set of features designed to provide users with unprecedented flexibility and accessibility to the world of digital humans. These features include: 1) Generation of Hyper-Realistic 3D Avatars: Antix offers an unprecedented level of realism in digital human avatars, with detailed facial features, setting a new standard for visual authenticity. 2) Behavior Selection & Creation: Users can choose from basic behavior scenarios designed for various types of interactions. 3) Voice Selection & Creation: Users can select a voice for their digital human from basic options based on their personality traits or use their own voice. 4) Multilevel Customization System: Using the marketplace, users can purchase various elements to customize their digital avatars. 5) Lifetime & Repair: All assets on the Antix platform are presented in the form of NFT, which allows you to transfer elements of realism to a digital environment. 6) Advanced AI Integration: The Antix platform incorporates cutting-edge AI technologies, including GPT-4.o support, which allows your digital human to interact with you. 7) Create & Customize a Personal Space: Immerse your digital human in a specially designed setting. 8) Static/Dynamic Content Production: Digital humans created in Antix exhibit realistic behavior and can be used to create various types of content. 9) Social Interaction: The social network within the Antix platform is built around digital humans, providing users with the opportunity to interact in a virtual space.
Pre-Sale
OYOFI Finance
The Platform is one stop solution for integrated Crypto DeFi Ecosystem Viz–A-Viz staking, Swapping, Tokenisation of Real World Assets and use of crypto assets in real world through OYOFI debit and credit card.
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Potentiam
The founders of Potentiam have worked in music management for a number of years and realise and understand the difficulties involved in promoting new emerging music artists. In 2016 they founded a music publication Britznbeatz to help discover and promote musicians which continues to gain respect and recognition in the industry.
Upcoming
Artcoin
The art world is traditionally anything but transparent, and that’s where ArtCoin, an investor-driven collective, creates real change for investors. Guiding users through transactions using cryptocurrencies, ArtCoin enables investors to benefit from the increased security and transparency of the Smart Contracts platforms. By pulling together information that everyday investors normally can’t access, ArtCoin democratizes the art market and acts as a direct liaison between investors and the art industry.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.